Total Payments
$15,948
2024 Payments
$1,441
Companies
42
Transactions
529
Medicare Patients
6,136
Medicare Billing
$533,132
Payment Breakdown by Category
Food & Beverage$13,911 (87.2%)
Travel$1,876 (11.8%)
Consulting$139.13 (0.9%)
Other$21.90 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,911 | 519 | 87.2% |
| Travel and Lodging | $1,876 | 8 | 11.8% |
| Consulting Fee | $139.13 | 1 | 0.9% |
| Entertainment | $21.90 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,848 | 88 | $0 (2024) |
| Cardiovascular Systems Inc. | $1,884 | 39 | $0 (2023) |
| Corindus Inc. | $1,449 | 6 | $0 (2018) |
| Penumbra, Inc. | $1,206 | 13 | $0 (2024) |
| Medtronic, Inc. | $1,082 | 33 | $0 (2024) |
| Boston Scientific Corporation | $938.94 | 28 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $726.21 | 44 | $0 (2024) |
| Medtronic Vascular, Inc. | $654.04 | 27 | $0 (2020) |
| Amgen Inc. | $568.70 | 38 | $0 (2024) |
| ShockWave Medical, Inc | $541.39 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,441 | 63 | Medtronic, Inc. ($359.56) |
| 2023 | $1,964 | 67 | Medtronic, Inc. ($362.99) |
| 2022 | $2,422 | 76 | Cardiovascular Systems Inc. ($547.57) |
| 2021 | $1,715 | 64 | Cardiovascular Systems Inc. ($470.00) |
| 2020 | $1,122 | 35 | Cardiovascular Systems Inc. ($574.17) |
| 2019 | $2,304 | 85 | Abbott Laboratories ($787.54) |
| 2018 | $2,875 | 77 | Corindus Inc. ($1,449) |
| 2017 | $2,105 | 62 | Abbott Laboratories ($646.57) |
All Payment Transactions
529 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $19.64 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/08/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/14/2024 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $158.87 | General |
| 11/13/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: Renal Denervation System | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | Medtronic, Inc. | FFRANGIO (Device) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Fractional Flow Reserve (FFR) Systems | ||||||
| 11/06/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: Vascular | ||||||
| 11/06/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: Vascular | ||||||
| 11/02/2024 | Medtronic, Inc. | FFRANGIO (Device) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Fractional Flow Reserve (FFR) Systems | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $108.16 | General |
| Category: Peripheral Intervention | ||||||
| 10/07/2024 | Medtronic, Inc. | FFRANGIO (Device) | Food and Beverage | In-kind items and services | $3.81 | General |
| Category: Fractional Flow Reserve (FFR) Systems | ||||||
| 10/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/20/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $18.90 | General |
| 09/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.32 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/10/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/23/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $153.15 | General |
| Category: Renal Denervation System | ||||||
| 08/16/2024 | Azurity Pharmaceuticals, Inc. | EDARBYCLOR (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/14/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $2.48 | General |
| Category: Renal Denervation System | ||||||
| 08/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/24/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $3.92 | General |
| Category: Vascular | ||||||
| 07/12/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $16.07 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/03/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,066 | 2,488 | $664,901 | $160,046 |
| 2022 | 20 | 1,443 | 1,789 | $499,094 | $120,259 |
| 2021 | 24 | 1,526 | 1,876 | $643,376 | $154,279 |
| 2020 | 20 | 1,101 | 1,415 | $431,269 | $98,548 |
Total Patients
6,136
Total Services
7,568
Medicare Billing
$533,132
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 191 | 286 | $139,486 | $39,932 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 196 | 229 | $83,315 | $21,497 | 25.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 100 | 102 | $100,776 | $20,808 | 20.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 32 | 40 | $78,560 | $18,885 | 24.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 108 | 112 | $35,942 | $8,177 | 22.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 324 | 491 | $28,969 | $5,364 | 18.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $19,348 | $4,610 | 23.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 64 | 66 | $17,226 | $4,071 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $17,632 | $3,878 | 22.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 504 | 568 | $22,720 | $3,854 | 17.0% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 41 | 47 | $14,899 | $3,715 | 24.9% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $15,060 | $3,577 | 23.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 58 | 59 | $14,278 | $3,398 | 23.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 33 | $11,319 | $3,356 | 29.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $16,126 | $3,191 | 19.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 31 | 31 | $13,017 | $3,113 | 23.9% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $9,600 | $1,985 | 20.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 139 | 160 | $6,720 | $1,641 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 20 | $4,940 | $1,581 | 32.0% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 18 | 19 | $6,023 | $1,149 | 19.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 87 | 94 | $4,606 | $1,088 | 23.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 14 | $3,360 | $946.96 | 28.2% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 11 | 11 | $979.00 | $228.48 | 23.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 109 | 181 | $88,147 | $25,776 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 195 | 238 | $86,394 | $22,200 | 25.7% |
About Dr. David Bartov, MD
Dr. David Bartov, MD is a Cardiovascular Disease healthcare provider based in New Providence, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1467616664.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Bartov, MD has received a total of $15,948 in payments from pharmaceutical and medical device companies, with $1,441 received in 2024. These payments were reported across 529 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($13,911).
As a Medicare-enrolled provider, Bartov has provided services to 6,136 Medicare beneficiaries, totaling 7,568 services with total Medicare billing of $533,132. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location New Providence, NJ
- Active Since 07/16/2008
- Last Updated 09/06/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1467616664
Products in Payments
- ELIQUIS (Drug) $991.79
- Indigo System (Device) $937.72
- Occluders (Device) $626.81
- Coronary Orbital Atherectomy System (Device) $592.12
- AMPLATZER Occluders (Device) $550.61
- Diamondback Coronary (Device) $479.66
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $477.73
- SYNERGY (Device) $453.68
- Repatha (Biological) $397.30
- ONYX FRONTIER (Device) $351.22
- XARELTO (Drug) $344.50
- Optis Coronary Imaging System (Device) $342.76
- Resolute (Device) $337.23
- Indigo (Device) $267.86
- OPTIS (Device) $265.59
- Impella (Device) $260.12
- SYMPLICITY G3 (Device) $258.03
- ENTRESTO (Drug) $249.79
- XIENCE SKYPOINT (Device) $226.20
- VERQUVO (Drug) $206.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in New Providence
Steven Sheris, Md, MD
Cardiovascular Disease — Payments: $16,396
Cardiovascular Disease $16,396
Dr. Sidney Glasofer, Md, MD
Cardiovascular Disease — Payments: $7,221
Cardiovascular Disease $7,221
John Farry, Md, MD
Cardiovascular Disease — Payments: $5,108
Cardiovascular Disease $5,108
Todd Rosenthal, M.b.b.s, M.B.B.S
Cardiovascular Disease — Payments: $4,019
Cardiovascular Disease $4,019
Robert Mich, Md, MD
Cardiovascular Disease — Payments: $472.70
Cardiovascular Disease $472.70
Andrew Adelsheimer, Md, MD
Cardiovascular Disease
Cardiovascular Disease